Why Evidence-Based AI Tools Win Trust — And General AI Doesn't
Trust in AI looks very different depending on which tool is doing the work. A new report from EBSCO Clinical Decisions surveyed 1,000 U.S. clinicians and 1,000 U.S. consumers to reveal a striking gap: evidence-based AI tools are earning clinician confidence, while general-purpose AI like ChatGPT is eroding patient trust.
Key Takeaways
- 80% of clinicians trust evidence-based AI-CDS tools, compared to widespread skepticism toward general AI models.
- 64% of consumers prefer seeing a professional who does not use AI at all. Yet when told the tool is evidence-based, 66% say their trust increases.
- 54% of consumers say their trust decreases if a general-purpose AI tool is involved in their care.
- AI-CDS saves real time: 75% of clinicians save four minutes or more per patient encounter; 87% say it frees up mental energy for clinical reasoning.
The report underscores a critical message for any organization deploying AI: how the tool is built and what data it's trained on matters as much as what it does. Evidence-based AI — traceable, verifiable, domain-specific — earns trust. Black-box general models don't.
🔗 Read the full article on Newswise
Stay in Rhythm
Subscribe for insights that resonate • from strategic leadership to AI-fueled growth. The kind of content that makes your work thrum.
More from Thrum
Additional pieces exploring adjacent ideas
